Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Equity Investments Gains from Equity Investments Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

INVO Fertility (IVF) Capital Expenditures (2016 - 2025)

INVO Fertility has reported Capital Expenditures over the past 9 years, most recently at $8062.0 for Q3 2025.

Quarterly Capital Expenditures changed N/A to $8062.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $110463.0 through Sep 2025, down 38.57% year-over-year, with the annual reading at $183703.0 for FY2024, 58.69% down from the prior year.
Capital Expenditures was $8062.0 for Q3 2025 at INVO Fertility, down from $8877.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $108217.0 in Q3 2023 and troughed at -$328537.0 in Q4 2021.
The 5-year median for Capital Expenditures is $8877.0 (2025), against an average of $6212.1.
Year-over-year, Capital Expenditures plummeted 1519.37% in 2021 and then skyrocketed 55655.56% in 2023.
A 5-year view of Capital Expenditures shows it stood at -$328537.0 in 2021, then skyrocketed by 99.96% to -$135.0 in 2022, then skyrocketed by 55655.56% to $75000.0 in 2023, then grew by 5.17% to $78874.0 in 2024, then plummeted by 89.78% to $8062.0 in 2025.
Per Business Quant, the three most recent readings for IVF's Capital Expenditures are $8062.0 (Q3 2025), $8877.0 (Q2 2025), and $14650.0 (Q1 2025).